Overview
1. Executive Summary (Confidence: High)
CARE is leading the European "prevention revolution" by making advanced diagnostic technology accessible, understandable, and actionable for the general public. Founded in Zurich, the company raised $6 million in 2023 to expand its unique health-optimization concept, which combines radiation-free full-body MRIs with intensive "blood tuning". CARE’s core value lies in its ability to synthesize data from 100+ biomarkers into a proprietary "CARE Score," allowing users to track their biological age and receive personalized, medically-backed action plans. Supported by a team of FMH-certified longevity experts and integrated with major Swiss supplemental insurers, CARE is effectively shifting the healthcare paradigm from reactive treatment to proactive prevention.
This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.